What AMC respiratory questions test
Respiratory questions cover the full range of care: the breathless patient in the emergency department, the smoker with a chronic cough in general practice, the post-operative patient with sudden chest pain on the ward. Most stems give you vital signs, an oxygen saturation, and often a chest X-ray description, spirometry or a blood gas. Your job is to name the problem and pick the next safe step.
The exam rewards knowing current Australian guidance. Asthma management in Australia changed in 2025, and a national lung cancer screening program began in July 2025. Many IMGs learned older regimens, so these are areas where up-to-date knowledge gives you easy marks.
Expect overlap with infectious diseases (tuberculosis, pneumonia), cardiology (PE, heart failure versus COPD), oncology (lung cancer), occupational health (asbestos, silica) and population health (smoking cessation, vaccination).
- Acute: severe asthma, COPD exacerbation, pneumonia, PE, pneumothorax, massive haemoptysis
- Chronic: asthma control, COPD stepwise care, bronchiectasis, interstitial lung disease, OSA
- Data interpretation: spirometry patterns, ABG acid-base and oxygenation, chest X-ray descriptions
- Prevention: smoking cessation, influenza and pneumococcal vaccination, lung cancer screening eligibility
High-yield topic 1: asthma and COPD
The 2025 Australian Asthma Handbook update is the most important recent change. For adults and adolescents aged 12 and over, salbutamol alone is no longer appropriate for confirmed asthma, even if symptoms are mild and infrequent. The preferred starting treatment is anti-inflammatory reliever (AIR) therapy: low-dose budesonide-formoterol taken as needed. If symptoms are frequent or flare-ups recur, step up to maintenance and reliever therapy (MART) with the same inhaler. An alternative pathway using regular ICS or ICS-LABA with a salbutamol reliever still exists for people who prefer other devices.
Acute severe asthma is still treated with repeated inhaled short-acting bronchodilator, systemic corticosteroid, and oxygen titrated to saturation. Signs of life-threatening asthma include inability to speak, drowsiness, a silent chest, exhaustion and a normal or rising carbon dioxide level. A normal PaCO2 in a breathless asthmatic is a warning sign, not reassurance. Consider IV magnesium and escalate early to ICU.
COPD in Australia follows the COPD-X guidelines from Lung Foundation Australia and TSANZ. Diagnosis needs post-bronchodilator spirometry showing an FEV1/FVC ratio below 0.7. Management is stepwise: smoking cessation, vaccination, pulmonary rehabilitation, then bronchodilators (LAMA, LABA, or both), with ICS added mainly for frequent exacerbations or features of asthma overlap. In exacerbations, target oxygen saturation of 88 to 92% in patients at risk of hypercapnia, use bronchodilators and oral prednisolone, give antibiotics when sputum becomes purulent, and use non-invasive ventilation for hypercapnic respiratory acidosis.
- New mild asthma, age 12 or older: as-needed budesonide-formoterol, not salbutamol alone
- Asthma diagnosis: variable airflow limitation; spirometry with significant bronchodilator response supports it
- Rising CO2 in acute asthma: impending respiratory failure, call ICU
- COPD exacerbation with pH low and CO2 high: NIV, controlled oxygen
- Pulmonary rehabilitation reduces breathlessness and readmissions; it is often the best non-drug answer
- Long-term oxygen therapy is for chronic hypoxaemia in a non-smoker, confirmed when stable; not for breathlessness alone
High-yield topic 2: pneumonia, tuberculosis and bronchiectasis
Community-acquired pneumonia questions test severity assessment and antibiotic choice using Therapeutic Guidelines: Antibiotic. Australian guidance uses severity tools such as SMART-COP and CORB alongside clinical judgement, rather than relying only on CURB-65 as UK sources do. Low-severity pneumonia in the community is usually treated with oral amoxicillin, or doxycycline where there is penicillin allergy or concern about atypical organisms. Moderate severity in hospital usually means IV benzylpenicillin plus a drug covering atypical organisms. High severity needs broader cover and ICU review.
Tropical northern Australia is different. In the wet season, severe pneumonia in a patient with diabetes, hazardous alcohol use or chronic kidney disease may be melioidosis (Burkholderia pseudomallei), and eTG recommends regimens that cover it in those regions. This is a classic Australian twist.
Australia has a low incidence of tuberculosis, and most cases occur in people born overseas in high-incidence countries. TB is notifiable, and treatment is coordinated through state and territory TB services. Latent TB is tested with an interferon-gamma release assay or tuberculin skin test. Active TB is confirmed with sputum microscopy, culture and nucleic acid testing; a patient with suspected pulmonary TB needs airborne isolation. Bronchiectasis presents with chronic productive cough and recurrent infection; it is common in Aboriginal and Torres Strait Islander children and adults, and high-resolution CT confirms it.
- Pneumonia not improving after 48 to 72 hours: think empyema, resistant organism, obstruction or wrong diagnosis
- Severe pneumonia in the Top End wet season with diabetes: consider melioidosis
- Cough over 3 weeks with weight loss in a migrant from a high-incidence country: sputum for TB, isolation
- Pneumococcal and influenza vaccination: check eligibility in the Australian Immunisation Handbook
High-yield topic 3: pulmonary embolism, pneumothorax and pleural effusion
For suspected PE, the decision pathway depends on pre-test probability. If clinical probability is low, PERC rules out PE without further testing when all criteria are met. If probability is low or intermediate and PERC cannot be applied, a negative D-dimer rules it out. If probability is high, go straight to imaging, usually CT pulmonary angiography. Use V/Q scanning when contrast is a concern, such as in significant renal impairment or contrast allergy, and it is often preferred in pregnancy with a normal chest X-ray. Massive PE with hypotension needs thrombolysis if not contraindicated. Most stable patients are treated with a DOAC, with warfarin or heparin in specific situations such as severe renal impairment, pregnancy or antiphospholipid syndrome.
Pneumothorax management has shifted. A large Australian and New Zealand randomised trial found that conservative management of moderate to large primary spontaneous pneumothorax was a reasonable alternative to drainage in stable patients. Tension pneumothorax is different: it is a clinical diagnosis with hypotension, tracheal deviation and absent breath sounds, and needs immediate decompression without waiting for an X-ray. Secondary pneumothorax in a patient with lung disease is less well tolerated and usually needs drainage and admission.
For pleural effusion, the key step is diagnostic aspiration and Light's criteria to separate a transudate (heart failure, cirrhosis, nephrotic syndrome) from an exudate (infection, malignancy, PE, TB). A unilateral effusion in a former tradesperson or a person exposed to asbestos raises concern for mesothelioma. A parapneumonic effusion with pH below 7.2, low glucose or pus needs drainage.
- PE in pregnancy: low-molecular-weight heparin; DOACs and warfarin are avoided
- Tension pneumothorax: decompress first, image later
- Bilateral effusions with heart failure features: treat the heart failure; tap only if atypical
- Empyema: chest drain and antibiotics; surgical referral if it does not resolve
High-yield topic 4: lung cancer, interstitial and occupational lung disease, OSA
Australia launched the National Lung Cancer Screening Program on 1 July 2025. It offers low-dose CT every two years to people aged 50 to 70 who have no symptoms, who currently smoke or quit within the past 10 years, and who have at least 30 pack-years of smoking history. This is now an examinable Australian difference. A patient with symptoms such as haemoptysis, persistent cough or weight loss does not belong in screening; they need diagnostic imaging, starting with chest X-ray and CT.
Lung cancer questions also test paraneoplastic and local effects: hypercalcaemia (squamous cell), SIADH and hyponatraemia (small cell), superior vena cava obstruction, Pancoast tumour with Horner syndrome, and recurrent laryngeal nerve palsy. Haemoptysis in a smoker over 40 needs urgent imaging. Massive haemoptysis is an airway emergency: position the patient with the bleeding side down, secure the airway and arrange bronchoscopy or embolisation.
Occupational lung disease is particularly relevant in Australia. Asbestos exposure in builders, electricians, plumbers and home renovators causes pleural plaques, asbestosis and mesothelioma decades later. Silicosis from engineered stone benchtops re-emerged in young stonemasons, and Australia banned the use of engineered stone from 1 July 2024. Interstitial lung disease presents with progressive breathlessness, dry cough, clubbing and fine inspiratory crackles; spirometry shows a restrictive pattern with reduced gas transfer. Sarcoidosis classically shows bilateral hilar lymphadenopathy, sometimes with erythema nodosum and raised calcium.
Obstructive sleep apnoea presents with snoring, witnessed apnoeas and daytime sleepiness, often with obesity and resistant hypertension. Diagnosis is by sleep study, and CPAP is the main treatment. Driving matters: excessive daytime sleepiness from OSA affects fitness to drive under the Austroads standards, and the exam can test your advice.
- Asymptomatic 58-year-old, 35 pack-years, quit 4 years ago: eligible for lung cancer screening
- Haemoptysis plus weight loss: diagnostic CT, not screening
- Young stonemason with breathlessness: silicosis, notify and remove from exposure
- OSA with sleepiness in a truck driver: driving advice under Austroads, sleep study, CPAP
Spirometry and blood gases: reading the numbers
Spirometry questions are pattern recognition. Obstructive disease (asthma, COPD, bronchiectasis) shows a reduced FEV1/FVC ratio below 0.7, often with a scooped flow-volume loop. Restrictive disease (interstitial lung disease, chest wall disease, obesity, neuromuscular weakness) shows a normal or raised ratio with reduced FVC. Gas transfer (DLCO) is reduced in interstitial lung disease and emphysema, and may be raised in pulmonary haemorrhage. Significant reversibility after bronchodilator supports asthma.
For ABGs, use a fixed order: pH, then PaCO2, then bicarbonate, then compensation, then oxygenation and the A-a gradient. Acute respiratory acidosis with a high PaCO2 and low pH in a drowsy COPD patient points to hypoventilation, often made worse by too much oxygen. Respiratory alkalosis with low PaCO2 and hypoxaemia suggests PE, pneumonia or early asthma. A raised A-a gradient means a lung problem; a normal A-a gradient with hypoxaemia suggests hypoventilation, such as opioid toxicity.
- FEV1/FVC below 0.7 after bronchodilator: obstruction, consistent with COPD in the right clinical setting
- Low FVC, normal ratio, low DLCO: interstitial lung disease
- High CO2, low pH, normal bicarbonate: acute respiratory acidosis
- High CO2, near-normal pH, high bicarbonate: chronic compensated retention
Australian differences and how to approach respiratory stems
Read the age, smoking history, occupation, country of birth and location in every stem. These details often decide the answer. A patient born in a high TB incidence country, a former builder, a remote community resident or someone from the Top End in the wet season is placed there for a reason.
Next, check the oxygen saturation and work of breathing. A patient who is tiring, drowsy or unable to speak needs escalation now, not another test. Then decide the stage of care: emergency, general practice or ward. Finally, match the answer to the Australian guideline for that condition.
- Asthma: AIR or MART with budesonide-formoterol for ages 12 and over; SABA-only treatment is no longer appropriate
- COPD: COPD-X stepwise care and pulmonary rehabilitation; oxygen target 88 to 92% if at risk of hypercapnia
- Pneumonia: eTG severity tools and regimens, with melioidosis cover in tropical regions
- TB: notifiable; managed through state TB services
- Lung cancer screening: national program for eligible people aged 50 to 70
- Silicosis: engineered stone ban since July 2024; occupational history is examinable
| Presentation in the stem | Likely diagnosis | Most appropriate next step |
|---|---|---|
| Young adult, new mild asthma, symptoms twice a month | Mild asthma | As-needed low-dose budesonide-formoterol (AIR) |
| Asthmatic, exhausted, silent chest, normal PaCO2 | Life-threatening asthma | Bronchodilators, steroids, IV magnesium, ICU review |
| Smoker, breathless, FEV1/FVC 0.58 after bronchodilator | COPD | Smoking cessation, vaccination, pulmonary rehab, LAMA or LABA |
| COPD, drowsy, pH 7.28, PaCO2 high | Hypercapnic respiratory failure | Non-invasive ventilation; controlled oxygen |
| Fever, cough, consolidation, stable vitals, at home | Low-severity pneumonia | Oral amoxicillin per eTG; review in 48 hours |
| Post-operative sudden breathlessness, tachycardia | Pulmonary embolism | Assess probability; CTPA if high |
| Hypotension, tracheal deviation, absent breath sounds | Tension pneumothorax | Immediate needle or finger decompression |
| Unilateral effusion, former builder, weight loss | Possible mesothelioma | Pleural aspiration and CT; specialist referral |
| Asymptomatic, 60, 32 pack-years, current smoker | Screening eligible | Refer to National Lung Cancer Screening Program |
| Snoring, daytime sleepiness, heavy vehicle driver | Obstructive sleep apnoea | Sleep study; driving advice under Austroads |
Worked examples in AMC style
Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for respiratory medicine.
Example 1
A 24-year-old woman sees her GP with wheeze and cough two or three times a month for six months, worse with exercise and cold air. She has no night waking. Spirometry shows a significant bronchodilator response. She has never used inhalers before and has no other medical history. She is not pregnant.
What is the most appropriate initial treatment?
-
The 2025 Australian Asthma Handbook says no adult or adolescent with confirmed asthma should use salbutamol alone, because of the risk of severe flare-ups.
-
Montelukast is not a preferred first step and does not give the exacerbation protection of an ICS-containing reliever.
-
High-dose combination therapy is excessive for mild asthma and exposes her to unnecessary steroid dose.
-
Correct. As-needed low-dose budesonide-formoterol (anti-inflammatory reliever therapy) is the preferred start for mild asthma in people aged 12 and over.
-
Oral steroids are for exacerbations, not for starting long-term treatment of mild asthma.
Show answer and reasoning
Answer: D. Budesonide-formoterol inhaler used only when needed
- A. The 2025 Australian Asthma Handbook says no adult or adolescent with confirmed asthma should use salbutamol alone, because of the risk of severe flare-ups.
- B. Montelukast is not a preferred first step and does not give the exacerbation protection of an ICS-containing reliever.
- C. High-dose combination therapy is excessive for mild asthma and exposes her to unnecessary steroid dose.
- D. Correct. As-needed low-dose budesonide-formoterol (anti-inflammatory reliever therapy) is the preferred start for mild asthma in people aged 12 and over.
- E. Oral steroids are for exacerbations, not for starting long-term treatment of mild asthma.
Mild asthma at age 12 or over in Australia: start as-needed budesonide-formoterol, never SABA alone.
Based on: Australian Asthma Handbook (2025 update), National Asthma Council Australia
Example 2
A 71-year-old man with severe COPD is brought to the emergency department with three days of increased breathlessness and purulent sputum. He is drowsy. Paramedics gave high-flow oxygen. His SpO2 is 99%. ABG shows pH 7.26, PaCO2 78 mmHg and bicarbonate 34 mmol/L. Chest X-ray shows hyperinflation without consolidation.
What is the most appropriate next step?
-
Excess oxygen worsens hypercapnia in at-risk COPD patients. His saturation of 99% is too high.
-
Correct. He has acute-on-chronic hypercapnic respiratory acidosis. COPD-X recommends controlled oxygen to 88 to 92% and NIV, plus bronchodilators, steroids and antibiotics for purulent sputum.
-
Aminophylline has a narrow therapeutic window and limited benefit. It is not the next step.
-
The story fits an infective exacerbation. PE imaging is not the priority while he is acidotic.
-
Intubation is considered if NIV fails or is contraindicated. NIV is the first-line ventilatory support.
Show answer and reasoning
Answer: B. Titrate oxygen to 88–92% and start NIV support
- A. Excess oxygen worsens hypercapnia in at-risk COPD patients. His saturation of 99% is too high.
- B. Correct. He has acute-on-chronic hypercapnic respiratory acidosis. COPD-X recommends controlled oxygen to 88 to 92% and NIV, plus bronchodilators, steroids and antibiotics for purulent sputum.
- C. Aminophylline has a narrow therapeutic window and limited benefit. It is not the next step.
- D. The story fits an infective exacerbation. PE imaging is not the priority while he is acidotic.
- E. Intubation is considered if NIV fails or is contraindicated. NIV is the first-line ventilatory support.
Hypercapnic COPD exacerbation: oxygen to 88–92% and NIV for respiratory acidosis.
Based on: COPD-X Plan: Australian and New Zealand guidelines for the management of COPD
Example 3
A 59-year-old man asks his GP about a lung check. He smoked 20 cigarettes a day from age 18 and quit six years ago. He has no cough, haemoptysis, weight loss or breathlessness. Examination is normal. His brother was recently diagnosed with lung cancer. He has no other health problems and works as an accountant.
What is the most appropriate next step?
-
Australia began a National Lung Cancer Screening Program in July 2025. He meets the eligibility criteria.
-
Chest X-ray is not a screening test for lung cancer; it misses early tumours.
-
Bronchoscopy is invasive and not indicated without symptoms or an imaging abnormality.
-
Sputum cytology has poor sensitivity and is not used for screening.
-
Correct. He is 59, asymptomatic, quit within 10 years and has about 41 pack-years, so he is eligible for low-dose CT screening every two years.
Show answer and reasoning
Answer: E. Refer for low-dose CT via the national program
- A. Australia began a National Lung Cancer Screening Program in July 2025. He meets the eligibility criteria.
- B. Chest X-ray is not a screening test for lung cancer; it misses early tumours.
- C. Bronchoscopy is invasive and not indicated without symptoms or an imaging abnormality.
- D. Sputum cytology has poor sensitivity and is not used for screening.
- E. Correct. He is 59, asymptomatic, quit within 10 years and has about 41 pack-years, so he is eligible for low-dose CT screening every two years.
Lung cancer screening in Australia: age 50–70, no symptoms, 30+ pack-years, current smoker or quit within 10 years.
Based on: Australian Government National Lung Cancer Screening Program
Quick recall
Tap a card to turn it over. If you can answer all eight without looking, move on to timed questions.
Where candidates lose marks
- SABA-only asthma treatment
Older textbooks start with salbutamol alone. Australian guidance now starts with as-needed budesonide-formoterol for ages 12 and over.
- High oxygen in COPD
A saturation of 99% in a hypercapnic COPD patient is too high and can worsen acidosis. Aim for 88 to 92%.
- Normal CO2 in severe asthma
A breathless asthmatic should have a low CO2. A normal or rising level means fatigue and impending failure.
- Screening the symptomatic patient
Haemoptysis, weight loss or persistent cough need diagnostic imaging, not entry into a screening program.
- Ignoring geography
Wet-season pneumonia in northern Australia may be melioidosis; standard regimens may not cover it.
How to study respiratory medicine
Day 1: Asthma. Learn the 2025 Australian Asthma Handbook changes (AIR and MART) and acute severe asthma management.
Day 2: COPD. Work through the COPD-X stepwise approach, exacerbation care, oxygen targets and NIV criteria.
Day 3: Infection. Pneumonia severity and eTG regimens, melioidosis, TB testing and isolation, bronchiectasis.
Day 4: PE, pneumothorax and pleural effusion. Practise the PE probability pathway and Light's criteria.
Day 5: Lung cancer, screening eligibility, ILD, occupational disease and OSA, then 20 spirometry and ABG questions.
Day 6: Mixed timed block of 40 respiratory questions. Note every answer that depended on an Australian guideline.
Sources and further reading
Check the current edition of each guideline before your exam. This page is study material, not clinical advice.
- Australian Asthma Handbook, National Asthma Council Australia
- COPD-X Plan: Australian and New Zealand guidelines for COPD
- Therapeutic Guidelines: Antibiotic and Respiratory
- National Lung Cancer Screening Program, Australian Government Department of Health
- Lung Foundation Australia
- Australian Immunisation Handbook
- Austroads: Assessing Fitness to Drive